Protein Acetylation in Age-Related Macular Degeneration: Mechanisms, Roles, and Therapeutic Perspectives

Tianyi Luo; Cunzi Li; Lan Zhou; Hongyan Sun; Ming Ming Yang

doi:10.1167/iovs.66.5.30

journal article Open Access May 22, 2025

Protein Acetylation in Age-Related Macular Degeneration: Mechanisms, Roles, and Therapeutic Perspectives

Tianyi Luo

Cunzi Li

Lan Zhou

Hongyan Sun

Ming Ming Yang

Investigative Opthalmology & Visual Science Vol. 66 No. 5 pp. 30 · Association for Research in Vision and Ophthalmology (ARVO)

View at Publisher Save 10.1167/iovs.66.5.30

Topics

No keywords indexed for this article. Browse by subject →

References

106

[1]

Flaxel "Age-related macular degeneration preferred practice pattern" Ophthalmology (2020) 10.1016/j.ophtha.2019.09.024

[2]

Fleckenstein "Age-related macular degeneration: a review" JAMA (2024) 10.1001/jama.2023.26074

[3]

Chew "Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36" JAMA Ophthalmol (2014) 10.1001/jamaophthalmol.2013.6636

[4]

Coleman "Age-related macular degeneration" Lancet (2008) 10.1016/s0140-6736(08)61759-6

[5]

Thomas "Age-related macular degeneration" Med Clin North Am (2021) 10.1016/j.mcna.2021.01.003

[6]

Mitchell "Age-related macular degeneration" Lancet (2018) 10.1016/s0140-6736(18)31550-2

[7]

Metelitsina "Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration" Invest Ophthalmol Vis Sci (2008) 10.1167/iovs.07-0526

[8]

Keenan "Age-related macular degeneration: epidemiology and clinical aspects" Adv Exp Med Biol (2021) 10.1007/978-3-030-66014-7

[9]

Wang "Protein modification and autophagy activation" Adv Exp Med Biol (2019) 10.1007/978-981-15-0602-4

[10]

Shahbazian "Functions of site-specific histone acetylation and deacetylation" Annu Rev Biochem (2007) 10.1146/annurev.biochem.76.052705.162114

[11]

Brooks "Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation" Curr Opin Cell Biol (2003) 10.1016/s0955-0674(03)00003-6

[12]

Hammond "Tubulin modifications and their cellular functions" Curr Opin Cell Biol (2008) 10.1016/j.ceb.2007.11.010

[13]

Arnesen "Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans" Proc Natl Acad Sci USA (2009) 10.1073/pnas.0901931106

[14]

Drazic "The world of protein acetylation" Biochim Biophys Acta (2016) 10.1016/j.bbapap.2016.06.007

[15]

Ree "Spotlight on protein N-terminal acetylation" Exp Mol Med (2018) 10.1038/s12276-018-0116-z

[16]

Varland "N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity" Nat Commun (2023) 10.1038/s41467-023-42342-y

[17]

Hwang "N-terminal acetylation of cellular proteins creates specific degradation signals" Science (2010) 10.1126/science.1183147

[18]

Yang "Lysine acetylation: codified crosstalk with other posttranslational modifications" Mol Cell (2008) 10.1016/j.molcel.2008.07.002

[19]

Gromyko "Depletion of the human Na-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition" Int J Cancer (2010) 10.1002/ijc.25275

[20]

Yi "Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival" Cell (2011) 10.1016/j.cell.2011.06.050

[21]

Haberland "The many roles of histone deacetylases in development and physiology: implications for disease and therapy" Nat Rev Genet. (2009) 10.1038/nrg2485

[22]

Shakespear "Histone deacetylases as regulators of inflammation and immunity" Trends Immunol (2011) 10.1016/j.it.2011.04.001

[23]

Chen "Post-translational modifications and their applications in eye research (Review)" Mol Med Rep (2017) 10.3892/mmr.2017.6529

[24]

Wang "Research progress on drusen in age-related macular degeneration" Int Rev Ophthalmol (2018)

[25]

Pool "Repository of proposed pathways and protein-protein interaction networks in age-related macular degeneration" NPJ Aging Mech Dis (2020) 10.1038/s41514-019-0039-5

[26]

Kushwah "Oxidative stress and antioxidants in age-related macular degeneration" Antioxidants (Basel) (2023) 10.3390/antiox12071379

[27]

Zhou "PGC-1a repression dysregulates lipid metabolism and induces lipid droplet accumulation in retinal pigment epithelium" Cell Death Dis (2024) 10.1038/s41419-024-06762-y

[28]

Zhang "Dysregulated metabolic pathways in age-related macular degeneration" Sci Rep (2020) 10.1038/s41598-020-59244-4

[29]

Zhang "Epigenetic regulation and retinal degenerative diseases" Chinese J Exp Ophthalmol (2022)

[30]

Buysschaert "Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis" J Cell Mol Med (2008) 10.1111/j.1582-4934.2008.00515.x

[31]

Gemenetzi "Epigenetics in age-related macular degeneration: new discoveries and future perspectives" Cell Mol Life Sci (2020) 10.1007/s00018-019-03421-w

[32]

Gemenetzi "The role of epigenetics in age-related macular degeneration" Eye (Lond) (2014) 10.1038/eye.2014.225

[33]

Desmettre "Epigenetics in age-related macular degeneration (AMD)" J Fr Ophtalmol (2018) 10.1016/j.jfo.2018.09.001

[34]

Shvedunova "Modulation of cellular processes by histone and non-histone protein acetylation" Nat Rev Mol Cell Biol (2022) 10.1038/s41580-021-00441-y

[35]

Olzscha "CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation" Cell Chem Biol (2017) 10.1016/j.chembiol.2016.11.009

[36]

Caballero "Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice" Nat Commun (2021) 10.1038/s41467-021-22501-9

[37]

Vermeulen "Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4" Cell (2007) 10.1016/j.cell.2007.08.016

[38]

Dahbash "The histone deacetylase inhibitor AN7, attenuates choroidal neovascularization in a mouse model" Int J Mol Sci (2019) 10.3390/ijms20030714

[39]

Qian "The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584" Cancer Res (2004) 10.1158/0008-5472.can-04-0540

[40]

Qian "Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589" Clin Cancer Res (2006) 10.1158/1078-0432.ccr-05-1132

[41]

Chan "Attenuation of choroidal neovascularization by histone deacetylase inhibitor" PLoS One (2015) 10.1371/journal.pone.0120587

[42]

Fong "Regulation of angiogenesis by oxygen sensing mechanisms" J Mol Med (Berl) (2009) 10.1007/s00109-009-0458-z

[43]

Arjamaa "Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors" Exp Eye Res (2006) 10.1016/j.exer.2006.01.016

[44]

Watroba "The role of sirtuins in aging and age-related diseases" Adv Med Sci (2016) 10.1016/j.advms.2015.09.003

[45]

Maloney "Expression of SIRT1 in choroidal neovascular membranes" Retina (2013) 10.1097/iae.0b013e31826af556

[46]

Crabb "Drusen proteome analysis: an approach to the etiology of age-related macular degeneration" Proc Natl Acad Sci USA (2002) 10.1073/pnas.222551899

[47]

Anderson "A role for local inflammation in the formation of drusen in the aging eye" Am J Ophthalmol (2002) 10.1016/s0002-9394(02)01624-0

[48]

Suuronen "Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells" Biochem Biophys Res Commun (2007) 10.1016/j.bbrc.2007.03.135

[49]

Gottlicher "Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells" EMBO J (2001) 10.1093/emboj/20.24.6969

[50]

Andrabi "Nitric oxide: physiological functions, delivery, and biomedical applications" Adv Sci (Weinh) (2023) 10.1002/advs.202303259

Showing 50 of 106 references

Metrics

3

Citations

106

References

Details

Published: May 22, 2025
Vol/Issue: 66(5)
Pages: 30
License: View

Authors

T

Tianyi Luo

The Second Clinical Medical College of Jinan University, Department of Ophthalmology, Shenzhen People's Hospital, Shenzhen, China

C

Cunzi Li

The Second Clinical Medical College of Jinan University, Department of Ophthalmology, Shenzhen People's Hospital, Shenzhen, China

L

Lan Zhou

Department of Ophthalmology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China; Post-doctoral Scientific Research Station of Basic Medicine, Jinan University, Guangzhou, China

H

Hongyan Sun

Department of Ophthalmology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China

M

Ming Ming Yang

Department of Ophthalmology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China

Cite This Article

Tianyi Luo, Cunzi Li, Lan Zhou, et al. (2025). Protein Acetylation in Age-Related Macular Degeneration: Mechanisms, Roles, and Therapeutic Perspectives. Investigative Opthalmology & Visual Science, 66(5), 30. https://doi.org/10.1167/iovs.66.5.30

Protein Acetylation in Age-Related Macular Degeneration: Mechanisms, Roles, and Therapeutic Perspectives

You May Also Like